PROPranolol eye DROPs in newborns with retinopathy of prematurity (DROP-PROP)
Not Applicable
Completed
- Conditions
- Retinopathy of prematurityEye Diseases
- Registration Number
- ISRCTN68126628
- Lead Sponsor
- A. Meyer University Children's Hospital (Italy)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
1. Preterm newborns (gestational age 23-32 weeks) with stage 2 ROP, zone II without plus
2. A signed parental informed consent
Exclusion Criteria
1. Newborns with heart failure
2. Newborns with congenital cardiovascular anomalies, except for persistent ductus arteriosus, patent foramen ovale and small ventricular septal defects
3. Newborns with recurrent bradycardia (heart rate < 90 beat per minute)
4. Newborns with second or third degree atrioventricular block
5. Newborns with hypotension
6. Newborns with renal failure
7. Newborns with actual cerebral haemorrhage
8. Newborns with other diseases which contraindicate the use of beta-adrenoreceptor blockers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method